Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema

NCT01796392 is registered in ClinicalTrials.gov with Pulmonx Corporation as lead sponsor.

NCT NCT01796392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01796392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema
Lead sponsor
Pulmonx Corporation
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2013
Completion date
April 30, 2023
Enrollment
190 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema